• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社会经济地位与澳大利亚生殖携带者筛查的接受情况。

Socioeconomic status and uptake of reproductive carrier screening in Australia.

机构信息

Department of Obstetrics and Gynaecology, Australian National University Medical School, Canberra, Australian Capital Territory, Australia.

Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

出版信息

Aust N Z J Obstet Gynaecol. 2020 Dec;60(6):976-979. doi: 10.1111/ajo.13206. Epub 2020 Aug 4.

DOI:10.1111/ajo.13206
PMID:32748403
Abstract

Reproductive carrier screening enables the early identification of genetic conditions that may impact the long-term health of a child, including cystic fibrosis, fragile X syndrome, and spinal muscular atrophy. We used unique data from the major providers of pathology services in Australia to profile women who intend on becoming, or who are, pregnant and access basic to advanced testing for genetic conditions. We found a strong socioeconomic gradient in the uptake of reproductive carrier screening, with women living in the most advantaged postcodes across Australia significantly being more likely to have reproductive carrier screening than those living in the most disadvantaged areas. These results highlight the need to minimise social and financial barriers that are currently limiting access.

摘要

生殖载体筛查使人们能够早期识别可能影响儿童长期健康的遗传疾病,包括囊性纤维化、脆性 X 综合征和脊髓性肌萎缩症。我们使用澳大利亚主要病理服务提供商的独特数据,对计划怀孕或已经怀孕的女性进行基因疾病的基本和高级检测,并对她们的情况进行了分析。我们发现,生殖载体筛查的普及程度存在明显的社会经济梯度,澳大利亚那些最富裕地区的女性比最贫困地区的女性更有可能接受生殖载体筛查。这些结果突显了需要尽量减少目前限制获得途径的社会和经济障碍。

相似文献

1
Socioeconomic status and uptake of reproductive carrier screening in Australia.社会经济地位与澳大利亚生殖携带者筛查的接受情况。
Aust N Z J Obstet Gynaecol. 2020 Dec;60(6):976-979. doi: 10.1111/ajo.13206. Epub 2020 Aug 4.
2
Making a (cautious) case for expanding reproductive genetic carrier screens: Australian researchers report success, and caveats, with a simultaneous panel of cystic fibrosis, fragile X syndrome, and spinal muscular atrophy.为扩大生殖基因携带者筛查提出(谨慎的)理由:澳大利亚研究人员报告了对囊性纤维化、脆性X综合征和脊髓性肌萎缩症进行联合检测的成功案例及注意事项。
Am J Med Genet A. 2018 Mar;176(3):510-512. doi: 10.1002/ajmg.a.38643.
3
Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.澳大利亚囊性纤维化、脆性 X 综合征和脊髓性肌萎缩症的生殖遗传携带者筛查:12000 次检测的结果。
Genet Med. 2018 Apr;20(5):513-523. doi: 10.1038/gim.2017.134. Epub 2017 Oct 26.
4
Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophy: patterns of community and healthcare provider participation in a Victorian screening program.囊性纤维化、脆性X综合征和脊髓性肌萎缩症的生殖遗传携带者筛查:维多利亚州筛查项目中社区和医疗服务提供者的参与模式
Aust J Prim Health. 2022 Dec;28(6):580-587. doi: 10.1071/PY21247.
5
Population screening for reproductive risk for single gene disorders in Australia: now and the future.澳大利亚单基因疾病生殖风险的人群筛查:现状与未来。
Twin Res Hum Genet. 2008 Aug;11(4):422-30. doi: 10.1375/twin.11.4.422.
6
"I'm Healthy, It's Not Going To Be Me": Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia.“我很健康,不会是我”:探索通过澳大利亚一项人群生殖遗传携带者筛查项目确定的携带者的经历。
Am J Med Genet A. 2016 Aug;170(8):2052-9. doi: 10.1002/ajmg.a.37697. Epub 2016 May 6.
7
Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.加拿大妇产科医师学会(SOGC)和加拿大医学遗传学会(CCMG)关于生殖遗传携带者筛查的联合意见:面向直接面向消费者检测时代所有加拿大孕产妇和生殖健康护理提供者的最新信息。
J Obstet Gynaecol Can. 2016 Aug;38(8):742-762.e3. doi: 10.1016/j.jogc.2016.06.008.
8
Outcomes of a cystic fibrosis carrier testing clinic for couples.针对夫妻的囊性纤维化携带者检测诊所的结果
Med J Aust. 2010 Feb 15;192(4):238; author reply 238-9. doi: 10.5694/j.1326-5377.2010.tb03491.x.
9
Expanded carrier screening in gamete donors of Venezuela.委内瑞拉配子捐赠者的扩大携带者筛查。
JBRA Assist Reprod. 2017 Dec 1;21(4):356-360. doi: 10.5935/1518-0557.20170062.
10
Expanded Carrier Screening.扩展型携带者筛查。
Obstet Gynecol Clin North Am. 2018 Mar;45(1):103-112. doi: 10.1016/j.ogc.2017.10.005.

引用本文的文献

1
Couple-Based Carrier Screening: How Gene and Variant Considerations Impact Outcomes.基于夫妻的携带者筛查:基因和变异因素如何影响筛查结果
Genes (Basel). 2025 May 30;16(6):671. doi: 10.3390/genes16060671.
2
Cost-effectiveness of population-based expanded reproductive carrier screening for genetic diseases in Australia: a microsimulation analysis.澳大利亚基于人群的扩大遗传性疾病生殖携带者筛查的成本效益:微观模拟分析
Eur J Hum Genet. 2025 Apr 16. doi: 10.1038/s41431-025-01835-8.
3
Pregnancy Planning and Genetic Testing: Exploring Advantages, and Challenges.
备孕与基因检测:探讨其优势与挑战。
Genes (Basel). 2024 Sep 13;15(9):1205. doi: 10.3390/genes15091205.
4
The Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission): Design and Implementation.澳大利亚生殖遗传携带者筛查项目(麦肯齐使命):设计与实施
J Pers Med. 2022 Oct 28;12(11):1781. doi: 10.3390/jpm12111781.
5
Genetic Counselling Needs for Reproductive Genetic Carrier Screening: A Scoping Review.生殖遗传携带者筛查的遗传咨询需求:一项范围综述
J Pers Med. 2022 Oct 11;12(10):1699. doi: 10.3390/jpm12101699.
6
Ethics of Reproductive Genetic Carrier Screening: From the Clinic to the Population.生殖遗传携带者筛查的伦理:从临床到人群
Public Health Ethics. 2021 Jun 14;14(2):202-217. doi: 10.1093/phe/phab017. eCollection 2021 Jul.
7
Ethical considerations in gene selection for reproductive carrier screening.用于生殖载体筛查的基因选择中的伦理考虑因素。
Hum Genet. 2022 May;141(5):1003-1012. doi: 10.1007/s00439-021-02341-9. Epub 2021 Aug 23.
8
Health practitioners' perceptions of the barriers and enablers to the implementation of reproductive genetic carrier screening: A systematic review.卫生保健从业者对实施生殖遗传携带者筛查的障碍和促进因素的看法:系统评价。
Prenat Diagn. 2021 May;41(6):708-719. doi: 10.1002/pd.5914. Epub 2021 Mar 5.